Understanding CAR T-cell Therapy as a Treatment Option for Blood Cancer Patients
 

 

David L. Porter, MD, Chair, University of Pennsylvania Health System, Philadelphia, PA
Steven Bair, MD, University of Pennsylvania Health System, Philadelphia, PA
Jacqueline C. Barrientos, MD, MS, Northwell Health Cancer Institute, New Hyde Park, NY
Ira Braunschweig, MD, Montefiore Medical Center, Bronx, NY
Adam D. Cohen, MD,  University of Pennsylvania Health System, Philadelphia, PA
Dennis L. Cooper, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 
Susan Dewolf, MD,  Memorial Sloan Kettering Cancer Center, New York, NY                                                                      
Heather DiFilippo, MSN, CRNP,  University of Pennsylvania Health System, Philadelphia, PA
Sergio A. Giralt, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Sukhdeep Kaur, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
Jamie L. Koprivnikar, MD, Hackensack University Medical Center, Hackensack, NJ
Deepu Madduri, MD, Mount Sinai Medical Center, New York, NY
Nigina Mirazimova, MSN, RN, OCN® , New York Presbyterian/ Weill Cornell, New York, NY
Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY
Ran Reshef, MD, MSc, Columbia University Irving Medical Center, New York, NY
Joanna M. Rhodes, MD, University of Pennsylvania Health System, Philadelphia, PA
Larysa Sanchez, MD, Mount Sinai Medical Center, New York, NY
Gunjan L. Shah, MD, Memorial Sloan Kettering Cancer Center, New York, NY                                                                        Mari Lynne Silverberg, MPA, RN, BSN, OCN®, Memorial Sloan Kettering Cancer Center, New York, NY
Koen van Besien, MD, PhD, New York-Presbyterian, Weill Cornell Medicine, New York, NY
Elizabeth A. Weber, BSN, RN, University of Pennsylvania Health System, Philadelphia, PA
Catherine Wei, MD,Rutgers Cancer Institute of New Jersey, New Brunswick, NJ